Skip to main content
. 2014 Oct 3;29(1):80–87. doi: 10.1038/eye.2014.233

Table 1. Comparison of baseline characteristics of four regimens, (N=36).

Baseline variable 0.5 mg monthly Mean (SD) aMedian 0.5 mg PRN Mean (SD) aMedian 2.0 mg monthly Mean (SD) aMedian 2.0 mg PRN Mean (SD) aMedian P values (entire study group)
Age 82.00 (6.20) 84.00 (6.00) 77.25 (6.24) 74.64 (9.44) 0.051
Gender Male: 0 Female: 6 Male: 1 Female: 6 Male: 5 Female: 7 Male: 4 Female: 7 0.21
RE vs LE RE: 3, LE: 3 RE: 5, LE: 2 RE: 10, LE: 2 RE: 6, LE: 5 0.38
Cataract:
 Cort 3.00a 2.00a 1.00a 0a 0.24 (Cort)
 NS 2.00 2.00 3.00 3.00 0.02 (NS)
 PSC 0 0 0 0 0.70 (PSC)
           
SRF 1.50a 1.00a 2.00a 1.00a 0.64
CME 1.00a 1.00a 0a 0a 0.15
BCVA (LS) 54.00 (6.63) 53.29 (14.35) 61.50 (7.21) 58.45 (8.35) 0.22 (LS)
CNV GLD 2763.28 (602.58) 2790.51 (1836.77) 1153.04 (751.54) 1858.03 (890.12) 0.083
CNV SA 3.35 (1.30) 5.15 (4.57) 1.06 (1.52) 1.85 (1.66) 0.061
PED GLD 4121.90 (437.70) 4372.49 (450.46) 4315.29 (1343.04) 3619.75 (1498.83) 0.47
Contrast sensitivity 24.20 (5.76) 27.00 (3.10) 25.73 (7.32) 27.10 (5.82) 0.67
PED SA 9.48 (1.35) 12.26 (3.72) 11.46 (7.52) 8.61 (7.07) 0.57
PED height 375.72 (198.27) 426.30 (149.59) 501.97 (197.71) 368.83 (145.55) 0.29
Central 1-mm thickness 281.17 (70.91) 336.57 (113.37) 311.17 (75.01) 297.45 (83.74) 0.67

Abbreviations: BCVA, best-corrected visual acuity; CME, cystoid macular edema; CNV, choroidal neovascularization; cort, cortical; GLD, greatest linear diameter; LE, left eye; LS, letter score; NS, nuclear sclerotic; PSC, posterior subcapsular; PRN, pro-re nata; RE, right eye; SA, surface area; SD, standard deviation; SRF, subretinal fluid.

a

χ2-analysis used for comparison of gender, RE vs LE, cataract, SRF, and CME. One-way ANOVA used for comparison of age, CNV GLD, CNV SA, PED GLD, PED SA, PED height, and central 1-mm thickness; one-way ANOVA used for the comparison of contrast sensitivity; Kruskal–Wallis Test used for the comparison of VA.